Quantcast

Latest Microarrays Stories

2014-02-06 16:32:00

DUBLIN, February 6, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/glj79b/global_next) has announced the addition of the "Global Next Generation Sequencing Market - Forecasts to 2016" [http://www.researchandmarkets.com/research/glj79b/global_next ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) With the expansion of the customer base to less sophisticated customers, access to improved...

2014-02-03 20:22:36

DUBLIN, February 3, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/6cwsz6/molecular) has announced the addition of the "Concise Analysis of the International Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/6cwsz6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with...

2014-01-31 23:24:23

OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, has been awarded a contract from the National Cancer Institute (NCI) to develop high affinity anti-peptide antibodies for SISCAPA assays. Rockville, MD (PRWEB) January 31, 2014 Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA), an approach developed by Dr. Leigh Anderson, is a novel technology that can achieve high...

2014-01-17 12:25:14

DUBLIN, January 17, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/zqlcks/biochip_products) has announced the addition of the "2013 Report on the US Biochip Products and Services Market - Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/zqlcks/biochip_products ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The U.S. biochip product market held majority...

2014-01-16 20:22:14

Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or "wet" age-related macular degeneration (AMD) SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (NASDAQ:SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an...

2014-01-14 16:26:12

SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, entered into an agreement to offer access to its MaterniT21(TM) PLUS laboratory-developed test to Mayo Medical Laboratories. "We are delighted to expand our offerings to our national clients to offer the MaterniT21 PLUS test to physicians who have patients who...

2014-01-12 12:20:22

SAN DIEGO, Jan. 12, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced preliminary highlights of the Company's 2013 performance, accomplishments and outlined key corporate objectives for 2014. Preliminary 2013 Performance Results (unaudited) -- Total revenue of approximately $162 million, showing growth of approximately 81% year-over-year for 2013 -- Diagnostic services...

2014-01-09 16:25:35

SAN DIEGO, Jan, 9, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits provider, to provide coverage for the MaterniT21(TM) PLUS laboratory-developed test (LDT). The addition of this contract brings the number of covered lives under agreement by Sequenom Laboratories' diagnostic...

2014-01-08 16:26:51

SAN DIEGO, Jan. 8, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today announced that on January 1, 2014, the European Patent Office (EPO) issued patent EP2183693 B1, entitled "Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing," invented by Drs. Dennis Lo, Rossa Chiu, and Kwan Chee Chan of The Chinese University of Hong Kong. The patent claims novel methods for detecting fetal...

2014-01-06 23:02:30

In-demand research report “Molecular Diagnostics in Cancer Testing” drawn up by TriMark Publications LLC (TriMark) has been recently published by Market Publishers Ltd. London, UK (PRWEB) January 06, 2014 Nowadays, molecular diagnostics (MD) represents a promising area of research and medicine, which is witnessing tremendous technology advancements alongside the emergence of novel applications. The range of technologies associated with MD includes, amid others, gene expression...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related